XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -9.60%24.34M | 5.51%54.5M | -2.58%26.92M | -8.49%51.65M | 53.25%27.63M | -8.75%56.44M | --18.03M | 68.08%61.86M | 116.83%36.8M | --16.97M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 8.61%-382K | -52.63%-1.98M | 52.87%-418K | 50.04%-1.29M | 60.98%-887K | 57.88%-2.59M | ---2.27M | -283.59%-6.15M | -315.28%-1.6M | ---386K |
Attributable subsidiary (profit) loss | 111.99%117K | 27.08%-4.2M | 74.53%-976K | -3.94%-5.76M | -81.78%-3.83M | 40.88%-5.54M | ---2.11M | -4,361.90%-9.37M | ---210K | ---- |
Impairment and provisions: | -132.39%-1.5M | -120.08%-520K | 472.95%4.62M | 903.49%2.59M | 492.65%806K | 104.76%258K | --136K | -38.54%126K | 373.33%205K | ---75K |
-Impairment of trade receivables (reversal) | -132.39%-1.5M | -120.08%-520K | 472.95%4.62M | 903.49%2.59M | 492.65%806K | 104.76%258K | --136K | -38.54%126K | 373.33%205K | ---75K |
Revaluation surplus: | ---- | ---1K | ---1K | ---- | ---- | ---- | ---- | ---- | 74.74%-74K | ---293K |
-Other fair value changes | ---- | ---1K | ---1K | ---- | ---- | ---- | ---- | ---- | 74.74%-74K | ---293K |
Asset sale loss (gain): | 155.81%24K | -90.13%22K | -178.18%-43K | 5,475.00%223K | 1,275.00%55K | -98.38%4K | --4K | 751.72%247K | 341.67%29K | ---12K |
-Loss (gain) on sale of property, machinery and equipment | 155.81%24K | -90.13%22K | -178.18%-43K | 5,475.00%223K | 1,275.00%55K | -98.38%4K | --4K | 751.72%247K | 341.67%29K | ---12K |
Depreciation and amortization: | 17.11%12.49M | 3.32%25.48M | -28.27%10.67M | 84.80%24.66M | 135.95%14.87M | 113.95%13.35M | --6.3M | 15.69%6.24M | 115.85%5.39M | --2.5M |
-Depreciation | 22.41%2.68M | 0.80%4.16M | -17.91%2.19M | 24.86%4.13M | 104.21%2.67M | 53.24%3.31M | --1.31M | -11.23%2.16M | 17.04%2.43M | --2.08M |
-Amortization of intangible assets | 4.02%207K | 0.25%397K | 1.02%199K | 2.59%396K | -38.82%197K | 1.85%386K | --322K | 235.40%379K | 37.80%113K | --82K |
Financial expense | -3.65%4.25M | 13.84%9.72M | 8.09%4.41M | -24.41%8.54M | -41.18%4.08M | 5.93%11.3M | --6.93M | 180.17%10.67M | 306.73%3.81M | --936K |
Exchange Loss (gain) | 41.91%-2.14M | ---- | ---3.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items | 145.86%2.23M | 114.90%2.03M | 3.78%905K | -48.05%946K | -12.97%872K | 502.88%1.82M | --1M | -157.22%-452K | -10.84%790K | --886K |
Adjustment items | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | -7.00%39.42M | 4.29%85.06M | -2.77%42.39M | 8.69%81.56M | 55.55%43.6M | 18.81%75.04M | --28.03M | 39.93%63.16M | 119.90%45.14M | --20.53M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -278.95%-72K | 1,400.00%13K | 26.92%-19K | -101.15%-1K | -145.61%-26K | -96.17%87K | --57K | 328.37%2.27M | 10.45%-994K | ---1.11M |
Accounts receivable (increase)decrease | -33.51%-40.64M | 38.28%-42.22M | 46.13%-30.44M | -468.48%-68.4M | -60.38%-56.5M | 41.58%-12.03M | ---35.23M | -138.70%-20.6M | -13.11%-8.63M | ---7.63M |
Accounts payable increase (decrease) | -103.14%-36M | 2,312.17%44.6M | -109.59%-17.72M | 127.99%1.85M | 38.46%-8.46M | -111.21%-6.61M | ---13.74M | 415.41%58.95M | -46.32%11.44M | --21.31M |
prepayments (increase)decrease | 18.11%-9.73M | -276.78%-21.53M | -350.44%-11.88M | -19.41%-5.71M | 16.92%-2.64M | -208.14%-4.79M | ---3.17M | 164.15%4.43M | -349.97%-6.9M | ---1.53M |
Special items for working capital changes | 716.82%8.14M | 100.46%74K | -198.29%-1.32M | -76.55%-15.96M | 140.66%1.34M | -245.61%-9.04M | ---3.3M | 652.61%6.21M | 233.93%825K | ---616K |
Cash from business operations | -104.75%-38.87M | 1,090.35%66.01M | 16.27%-18.99M | -115.62%-6.67M | 17.12%-22.68M | -62.71%42.66M | ---27.36M | 179.90%114.42M | 32.11%40.88M | --30.95M |
Other taxs | 16.10%-8.74M | -26.38%-12.49M | -27.24%-10.41M | 18.61%-9.89M | 23.69%-8.18M | -8.13%-12.15M | ---10.73M | -173.04%-11.23M | -9.33%-4.11M | ---3.76M |
Interest received - operating | 18.40%341K | ---- | -52.16%288K | ---- | 227.17%602K | -12.17%433K | --184K | -32.28%493K | 88.60%728K | --386K |
Net cash from operations | -62.38%-47.27M | 423.32%53.51M | 3.79%-29.11M | -153.47%-16.55M | 20.16%-30.26M | -70.15%30.95M | ---37.9M | 176.53%103.68M | 36.01%37.49M | --27.57M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -68.46%41K | 52.63%1.98M | -54.39%130K | -40.01%1.29M | -86.36%285K | -61.86%2.16M | --2.09M | 546.40%5.66M | --875K | ---- |
Dividend received - investment | ---- | ---- | ---- | -37.15%3.62M | ---- | 100.31%5.76M | ---- | --2.87M | ---- | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | -102.82%-3.62M | -102.90%-3.62M | 235.45%128.46M | --124.84M | -216.13%-94.84M | ---30M | ---- |
Sale of fixed assets | 18.52%224K | 6.47%888K | -37.83%189K | 411.66%834K | 2.70%304K | -73.01%163K | --296K | 102.01%604K | 11.57%299K | --268K |
Purchase of fixed assets | -117.87%-3.16M | 3.71%-5.71M | 89.49%-1.45M | 6.83%-5.93M | -566.01%-13.79M | -50.40%-6.37M | ---2.07M | 12.56%-4.23M | 14.27%-4.84M | ---5.65M |
Purchase of intangible assets | ---- | -5.26%-20K | ---- | 67.80%-19K | ---- | 97.53%-59K | ---- | -139.04%-2.39M | -1,413.64%-999K | ---66K |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --206K | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---124.8M | ---- |
Recovery of cash from investments | -183.33%-50M | --65M | --60M | ---- | ---- | ---- | ---- | --5M | ---- | ---- |
Cash on investment | 172.24%48.22M | -157.90%-69.31M | -455.58%-66.75M | ---26.88M | ---12.01M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 40.66%-4.67M | 76.61%-7.18M | 72.68%-7.88M | -123.60%-30.7M | -123.04%-28.84M | 249.34%130.11M | --125.15M | 45.37%-87.12M | -2,828.20%-159.47M | ---5.45M |
Net cash before financing | -40.43%-51.94M | 198.06%46.33M | 37.41%-36.99M | -129.34%-47.25M | -167.73%-59.09M | 872.58%161.06M | --87.25M | 113.58%16.56M | -651.38%-121.98M | --22.12M |
Cash flow from financing activities | ||||||||||
New borrowing | -49.94%20M | 7.65%43.06M | 33.17%39.95M | -63.64%40M | -40.00%30M | -47.35%110M | --50M | 81.66%208.91M | 505.26%115M | --19M |
Refund | -27.15%-28.1M | 22.64%-33.14M | 47.13%-22.1M | 80.71%-42.84M | 65.75%-41.8M | -93.12%-222.09M | ---122.05M | -505.26%-115M | -90.00%-19M | ---10M |
Issuing shares | ---- | --110.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | 3.65%-4.25M | -13.84%-9.72M | -8.09%-4.41M | 24.41%-8.54M | 41.18%-4.08M | -5.93%-11.3M | ---6.93M | -180.17%-10.67M | -306.73%-3.81M | ---936K |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 99.94%-6K | ---- | ---10M | ---- | ---- |
Absorb investment income | ---- | --138K | --102.5M | ---- | ---- | 84.36%2.03M | --2.03M | --1.1M | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---8.52M | ---839K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Pledged bank deposit (increase) decrease | ---- | ---- | ---- | 160.00%6M | --6M | ---10M | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | -434.31%-21.1M | ---31.1M | ---3.95M | ---- | ---- |
Net cash from financing operations | -118.58%-20.12M | 937.87%84.34M | 853.67%108.25M | 93.65%-10.07M | 86.86%-14.36M | -332.99%-158.4M | ---109.29M | -25.66%67.99M | 1,276.36%91.46M | --6.65M |
Effect of rate | -41.91%2.14M | ---- | --3.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items affecting net cash | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | -201.12%-72.06M | 327.99%130.67M | 197.01%71.26M | -2,257.17%-57.32M | -233.33%-73.46M | -96.86%2.66M | ---22.04M | 377.05%84.55M | -206.08%-30.52M | --28.77M |
Begining period cash | 202.08%195.34M | -46.99%64.66M | -46.99%64.66M | 2.23%121.98M | 2.23%121.98M | 243.13%119.32M | --119.32M | -46.74%34.78M | 78.76%65.29M | --36.53M |
Cash at the end | -10.17%125.42M | 202.08%195.34M | 187.73%139.62M | -46.99%64.66M | -50.12%48.52M | 2.23%121.98M | --97.29M | 243.13%119.32M | -46.74%34.78M | --65.29M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.